
The zzso zzso zzso target of zzso inhibitor zzso zzso is often zzso activated in human tumor cells, providing unique opportunities for zzso therapeutic zzso zzso is an zzso zzso that zzso zzso and zzso zzso activity by binding to the zzso zzso of these zzso In cellular settings using human tumor cell lines, this zzso is able to effectively and specifically block the dysfunctional zzso of the zzso pathway, inducing zzso zzso The cellular activity of zzso translates well in in zzso models of human zzso Thus, the compound was well zzso displayed disease stasis when administered orally, and enhanced the efficacy of other zzso agents when used in in zzso combination zzso zzso zzso zzso analyses of tumor zzso showed a zzso correlation between compound concentration and zzso zzso zzso zzso the zzso data show that zzso is a potent dual zzso zzso with favorable pharmaceutical zzso zzso is currently in phase I clinical zzso 

